Detalles de la búsqueda
1.
Final report of TKI discontinuation trial with dasatinib for the second attempt of treatment-free remission after failing the first attempt with imatinib: Treatment-free Remission Accomplished by Dasatinib (TRAD) study.
Br J Haematol
; 203(5): 781-791, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697469
2.
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patients.
Ann Hematol
; 100(6): 1439-1449, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33932168
3.
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patients.
Am J Hematol
; 95(12): E323-E326, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32864747
4.
Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase.
Hematology
; 29(1): 2329027, 2024 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38526239
5.
Mutations in myeloid transcription factors and activated signaling genes predict chronic myeloid leukemia outcomes.
Blood Adv
; 8(10): 2361-2372, 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38447114
6.
Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report.
EJHaem
; 3(4): 1374-1376, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36467820
7.
Asparaginase completion among adults including older patients with acute lymphoblastic leukemia treated with a modified DFCI protocol.
Leukemia
; 38(4): 912-913, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38431747
Resultados
1 -
7
de 7
1
Próxima >
>>